Editas Medicine

NASDAQ

EDITAS

Stock

Yield per half year: 0%
Dividend yield: 0%
Sector: Healthcare

Compare companies

Download the report:

Excel

Word

PDF

	Editas Medicine	Gilead Sciences	Amgen
Capitalization
Price		114.55	276.39
Price priv.
Number of shares, million		1255	541
Capitalization, billion	0.579	150.63	154.17
EBITDA, billion	-0.2036	4.43	13.36
EV, billion	0.339	132.19	188.41
Profit and loss report
Net profit, billion	-0.1935	0.48	4.09
Revenue, bln, billion	0.067	28.75	33.42
EPS	0	0.3825	7.56
Balance
Assets, bln, billion	0.3848	59	91.84
Debt, bln, billion	0.0387	26.71	60.1
Balance cost, billion	0.232	19.33	5.88
Cash, bln, billion	0.2791	9.99	11.97
Coefficients
Dividend yield, %	0	2.88	3.07
Dividend	0	3.14	9.39
Dividend yield priv., %	0	0	0
Dividend priv.	0	0	0
Dividends/profit, %	0	816.25	118.14
P/S	0	4.02	4.2
P/BV	0	6	23.87
P/E	0	240.57	34.3
Ev/Ebitda	0	29.81	14.11
Debt/Ebitda	-0.1901	6.02	4.5
Efficiency
ROE	0	2.28	67.55
ROA	0	0.7926	4.33
ROIC	0	11.06	17
Ebitda margin	-303.88	15.42	39.96
Net margin	0	1.67	12.24
Momentum
1 week, price changes	0 %	-2.78 %	-1.36 %
1 month, price changes	0 %	-1.94 %	-5.9 %
3 months, price changes	0 %	+2.65 %	-7.98 %
6 months, price changes	0 %	+14.65 %	+0.1994 %
1 year, price changes	0 %	+19.58 %	+5.02 %
3 years, price changes		+29.62 %	+0.9128 %
5 years, price changes		+65.82 %	+13.85 %
10 years, price changes		+64.17 %	+69.45 %

More data >>

Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe